Roivant Sciences Director Keith Manchester Receives Annual Equity Awards
Roivant Sciences Ltd.
Subscribe to track ROIV
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
# Insider Transaction Report: Roivant Sciences Ltd. (NASDAQ: ROIV)
**Insider:** Keith S. Manchester
**Role:** Director
**Transaction Date:** September 16, 2026
**Filing Date:** September 18, 2026
**Significance:** Low (Routine Annual Director Grant)
### Non-Derivative Transactions
- **Type:** Restricted Stock Units (RSUs) Grant (Code A)
- **Shares:** 5,054 Common Shares
- **Price:** $0.00
- **Shares Owned After:** 1,753,457 (Direct)
### Derivative Transactions
- **Type:** Stock Option (Right to Buy)
- **Underlying Shares:** 10,531 Common Shares
- **Exercise Price:** $39.57
- **Expiration Date:** September 15, 2036
*Note: Awards vest 100% on September 16, 2027 pursuant to the Non-Employee Director Compensation Policy.*
Comprehensive Analysis
Executive Summary
On September 18, 2026, Roivant Sciences Ltd. (ROIV) filed a Form 4 reporting annual equity incentive grants awarded to Director Keith S. Manchester. On September 16, 2026, Dr. Manchester received 5,054 Restricted Stock Units (RSUs) and an option to purchase 10,531 Common Shares at an exercise price of $39.57 per share.
Key Transaction Highlights
- Restricted Stock Units: 5,054 RSUs were granted under the Company's 2021 Equity Incentive Plan and Non-Employee Director Compensation Policy at $0 cost.
- Stock Options: 10,531 options granted with an exercise price of $39.57, expiring on September 15, 2036.
- Vesting Terms: Both awards are scheduled to vest 100% on September 16, 2027, subject to continued service as a director.
- Post-Transaction Holdings: Direct ownership of common shares stands at 1,753,457 shares following the transaction.
Market Impact & Significance
This filing reflects routine annual equity compensation granted in accordance with Roivant Sciences' standard Non-Employee Director Compensation Policy. Because it represents a non-discretionary equity award rather than an open-market purchase or sale, the trading significance is rated as Low and does not signify directional insider sentiment.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.